We are live on ! Find out more
FUSN

Fusion Pharmaceuticals Inc. Common Shares
FUSN

Delisted

FUSN was delisted on the 3rd of June, 2024.

Back to rankings

29 hedge funds and large institutions have $304M invested in Fusion Pharmaceuticals Inc. Common Shares in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

37% less capital invested

Capital invested by funds: $483M → $304M (-$179M)

38% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 8

43% less funds holding

Funds holding: 51 → 29 (-22)

81% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 27

Holders
29
Holders Change
-22
Holders Change %
-43.14%
% of All Funds
0.59%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
5
Increased
5
Reduced
8
Closed
27
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$2.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.17M
3
SFI
Susquehanna Fundamental Investments
Pennsylvania
+$543K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$316K
5
RSCM
Rock Springs Capital Management
Maryland
+$144K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$8.81M
2
Citadel Advisors
Citadel Advisors
Florida
-$5.68M
3
DM
Deerfield Management
New York
-$3.89M
4
UBS AM
UBS AM
Illinois
-$3.11M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$3.11M
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$4K – – –
S
27
SignatureFD
Georgia
$4K – – –
Millennium Management
28
Millennium Management
New York
$2.2K -$380K -27,789 -13%
APA
29
American Portfolios Advisors
New York
$361 +$410 +30 New
Citadel Advisors
30
Citadel Advisors
Florida
– -$5.68M -325,001 Closed
UBS AM
31
UBS AM
Illinois
– -$3.11M -178,155 Closed
Janus Henderson Group
32
Janus Henderson Group
United Kingdom
– -$3.11M -177,845 Closed
Invesco
33
Invesco
Georgia
– -$2.97M -170,000 Closed
APM
34
Avidity Partners Management
Texas
– -$2.88M -164,554 Closed
HM
35
HealthCor Management
New York
– -$2.62M -150,000 Closed
ACP
36
Acuta Capital Partners
California
– -$2.36M -135,000 Closed
LGM
37
Logos Global Management
California
– -$2.12M -121,128 Closed
Blackstone Inc
38
Blackstone Inc
New York
– -$1.05M -60,000 Closed
Point72 Asset Management
39
Point72 Asset Management
Connecticut
– -$1.05M -60,000 Closed
MIM
40
Monashee Investment Management
Massachusetts
– -$874K -50,000 Closed
Tudor Investment Corp
41
Tudor Investment Corp
Connecticut
– -$509K -29,145 Closed
MS
42
Maven Securities
Jersey
– -$437K -25,000 Closed
PAMU
43
Pictet Asset Management (UK)
United Kingdom
– -$401K -22,973 Closed
ZP
44
Zimmer Partners
New York
– -$393K -22,500 Closed
Wells Fargo
45
Wells Fargo
California
– -$271K -15,517 Closed
DKCM
46
Davidson Kempner Capital Management
New York
– -$263K -15,000 Closed
CM
47
Crestline Management
Texas
– -$175K -10,000 Closed
Voloridge Investment Management
48
Voloridge Investment Management
Florida
– -$175K -10,000 Closed
PHK
49
Point72 Hong Kong
Hong Kong
– -$140K -8,019 Closed
UBS Group
50
UBS Group
Switzerland
– -$96K -5,484 Closed
1
2
3

FUSN Hedge Fund Activity: Q3 2020 in Review

29 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Fusion Pharmaceuticals Inc. Common Shares (FUSN) for Q3 2020, worth a combined $304M — down 37% from $483M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of FUSN and 5 opened new positions — a net loss of 22 holders — while 8 trimmed existing stakes and 5 added.

The largest buyer was Federated Hermes, adding an estimated $2.6M. The largest seller was Morgan Stanley, cutting an estimated $8.81M.

  • 29 institutional investors held Fusion Pharmaceuticals Inc. Common Shares (FUSN) as of Q3 2020, down from 51 in Q2 2020.
  • Funds reported $304M of Fusion Pharmaceuticals Inc. Common Shares stock for Q3 2020, down 37% quarter-over-quarter.
  • 5 funds opened new Fusion Pharmaceuticals Inc. Common Shares positions in Q3 2020 and 27 closed out, a net change of -22 holders.
  • The largest Fusion Pharmaceuticals Inc. Common Shares buyer in Q3 2020 was Federated Hermes, an estimated $2.6M added.
  • The largest Fusion Pharmaceuticals Inc. Common Shares seller in Q3 2020 was Morgan Stanley, an estimated $8.81M sold.

Based on aggregated 13F filings for Q3 2020.